Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?: A Systematic Review and Critical Appraisal

Conclusions The use of rituximab for the treatment of pSS-related fatigue cannot be supported by the currently available evidence.
Source: JCR: Journal of Clinical Rheumatology - Category: Rheumatology Tags: Reviews Source Type: research
More News: Rheumatology | Rituxan